Drug-Eluting Stent Use Among Low-Income Patients in Maharashtra After Statewide Price Reductions

Circ Cardiovasc Interv. 2019 Apr;12(4):e007757. doi: 10.1161/CIRCINTERVENTIONS.118.007757.

¹ Department of Cardiology, All India Institute of Medical Sciences, Rishikesh, India (B.D.).
² Michigan Integrated Center for Health Analytics and Medical Prediction, Department of Internal Medicine (B.G., K.S., B.K.N.), University of Michigan, Ann Arbor.
³ Department of Community Medicine, Post-Graduate Institute of Medical Education and Research, Chandigarh, India (M.D.).
⁴ Takemi Fellow, Harvard School of Public Health; Department of Health and Family Welfare, Government of Maharashtra, India (S.S.).
⁵ Department of Computer Science, Indraprastha Institute of Information Technology, Delhi, India (P.S.).
⁶ Council of Scientific and Industrial Research, Institute of Genomics and Integrative Biology, New Delhi, India (A.A.).
⁷ Department of Internal Medicine, NYU Langone, New York (P.W.).
⁸ Ross School of Business (R.A.), University of Michigan, Ann Arbor.

No abstract available

Keywords: coronary artery disease; drug-eluting stent; human; percutaneous coronary intervention; vulnerable population.

Publication types